CL2011000222A1 - Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras. - Google Patents

Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras.

Info

Publication number
CL2011000222A1
CL2011000222A1 CL2011000222A CL2011000222A CL2011000222A1 CL 2011000222 A1 CL2011000222 A1 CL 2011000222A1 CL 2011000222 A CL2011000222 A CL 2011000222A CL 2011000222 A CL2011000222 A CL 2011000222A CL 2011000222 A1 CL2011000222 A1 CL 2011000222A1
Authority
CL
Chile
Prior art keywords
chitosan
alopecia
hair
alpha
composition containing
Prior art date
Application number
CL2011000222A
Other languages
English (en)
Inventor
Federico Mura Emanuela Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of CL2011000222A1 publication Critical patent/CL2011000222A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9741—Pteridophyta [ferns]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

Composición que contiene a)Quitosano o un derivado, b) Al menos 1 ingrediente seleccionado de inhibidores de alfa-5-reductasa, antiandrógenos, agonistas del canal de K, aminoácidos, entre otros, y c) Por lo menos un solvente volátil; y su uso para afecciones del cabello tal como alopecia, caída del cabello, entre otras.
CL2011000222A 2008-08-04 2011-02-01 Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras. CL2011000222A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08161757A EP2153836A1 (en) 2008-08-04 2008-08-04 Film-forming liquid formulations for drug release to hair and scalp

Publications (1)

Publication Number Publication Date
CL2011000222A1 true CL2011000222A1 (es) 2011-10-07

Family

ID=40221455

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000222A CL2011000222A1 (es) 2008-08-04 2011-02-01 Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras.

Country Status (28)

Country Link
US (1) US8303997B2 (es)
EP (3) EP2153836A1 (es)
JP (1) JP5677299B2 (es)
KR (1) KR101661251B1 (es)
CN (2) CN102112137A (es)
AR (1) AR072912A1 (es)
AU (1) AU2009278086B2 (es)
BR (1) BRPI0917231B1 (es)
CA (1) CA2732582C (es)
CL (1) CL2011000222A1 (es)
CY (1) CY1123334T1 (es)
DK (1) DK2307031T3 (es)
EA (1) EA021133B1 (es)
ES (1) ES2820304T3 (es)
HR (1) HRP20201385T1 (es)
HU (1) HUE052093T2 (es)
IL (1) IL210920A (es)
LT (1) LT2307031T (es)
MA (1) MA32600B1 (es)
MX (1) MX2011001380A (es)
MY (1) MY158566A (es)
NZ (1) NZ590796A (es)
PE (1) PE20110414A1 (es)
PT (1) PT2307031T (es)
RS (1) RS60781B1 (es)
SI (1) SI2307031T1 (es)
WO (1) WO2010015556A1 (es)
ZA (1) ZA201100706B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2702982T3 (pl) * 2011-04-25 2017-07-31 Jun-Hyoung Park Kompozycja do miejscowego stosowania do zapobiegania wypadaniu włosów i stymulowania porostu włosów
ES2517741B1 (es) * 2013-04-30 2015-09-09 Lacer, S.A. Composición para reducir y/o prevenir la caída del cabello y/o estimular su crecimiento
WO2014185461A1 (ja) * 2013-05-15 2014-11-20 ライオン株式会社 育毛剤組成物
JP5815774B2 (ja) * 2014-02-27 2015-11-17 一般社団法人グリーンエバー サルファ剤およびキトサン剤を含む、発毛および／または育毛促進組成物
CN105658223B (zh) 2014-05-23 2018-12-04 特里普海尔公司 用于减少脱发和/或增加毛发再生的组合物
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
PL3347009T3 (pl) 2015-07-08 2022-02-07 Triple Hair Inc. Kompozycja zawierająca resweratrol i melatoninę ograniczająca wypadanie włosów i/lub zwiększająca odrastanie włosów
AU2016381976B2 (en) * 2015-12-31 2019-12-19 Colgate-Palmolive Company Cleansing compositions
AR108116A1 (es) * 2016-04-11 2018-07-18 Biolab Sanus Farmaceutica Ltda Composición dermocosmética, proceso de producción de la composición tópica, método para fortalecimiento de uñas frágiles y uso de la composición
CN106478758A (zh) * 2016-10-08 2017-03-08 佛山市聚成生化技术研发有限公司 一种辣木内β‑谷甾醇的提取工艺及其应用
CN106821907A (zh) * 2017-02-14 2017-06-13 玉林祺钟商贸有限公司 一种高效护发化妆品及制作方法
WO2018206077A1 (en) 2017-05-08 2018-11-15 Merz Pharma Gmbh & Co. Kgaa Emulsion comprising finasteride
WO2018228700A1 (en) 2017-06-16 2018-12-20 Merz Pharma Gmbh & Co. Kgaa Finasteride for use in the treatment of androgenetic alopecia
CN108324610B (zh) * 2018-03-20 2019-09-20 珀莱雅化妆品股份有限公司 一种生发组合物及其pic油包水纳米乳液的制备方法
CN108815066B (zh) * 2018-06-14 2019-10-15 广州植境生物科技有限公司 一种含稷籽提取物的草本护发组合物
CA3110856C (en) 2018-08-26 2024-05-28 Hair Plus Health Llc Methods and compositions to increase hair growth and/or prevent hair loss
WO2020122681A1 (en) 2018-12-14 2020-06-18 Chong Kun Dang Pharmaceutical Corp. Composition comprising dutasteride
CN110339134B (zh) * 2019-08-22 2020-10-16 广州馥邦科技应用有限公司 一种防治脱发组合物、防治脱发产品及其制备方法
JP2022550595A (ja) * 2019-10-04 2022-12-02 リビング プルーフ インコーポレイテッド キトサンおよびヒドロキシプロピルメチルセルロースを含む化粧品組成物ならびに毛髪強度および関連特性を向上させるためのそれらの使用
CN112315840A (zh) * 2020-11-20 2021-02-05 广州植境生物科技有限公司 一种贻贝粘蛋白头皮修护组合物、修护液及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3614697A1 (de) * 1986-04-30 1987-11-05 Wella Ag Kosmetische mittel auf der basis von n-hydroxybutyl-chitosanen, neue n-hydroxybutyl-chitosane sowie verfahren zu ihrer herstellung
JP4185173B2 (ja) 1997-08-07 2008-11-26 株式会社ノエビア 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤
IL142598A0 (en) * 1998-10-23 2002-03-10 Aventis Pharma Gmbh Preparations for topical application of substances having antiandrogenic effect
FR2787712B1 (fr) * 1998-12-24 2002-08-30 Sanofi Sa Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique
JP2000290143A (ja) * 1999-03-31 2000-10-17 Lion Corp 毛髪化粧料
JP2001019624A (ja) * 1999-07-08 2001-01-23 Toho:Kk 毛髪処理用組成物
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR20020048534A (ko) 2000-12-18 2002-06-24 안병로 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제
SE0100166D0 (sv) 2001-01-22 2001-01-22 Tacton Systems Ab Configuration system
EP1387676A2 (en) * 2001-05-01 2004-02-11 Angiotech Pharmaceuticals, Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
KR100457546B1 (ko) 2001-05-02 2004-11-18 주식회사 바이오프로젠 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법
JP4619581B2 (ja) * 2001-08-10 2011-01-26 花王株式会社 毛髪化粧料
GB0126923D0 (en) 2001-11-09 2002-01-02 Procter & Gamble Chitosan compositions
JP2004231604A (ja) 2003-01-31 2004-08-19 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai 担体シートおよび徐放性製剤ならびにそれらの製法
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
US20050112151A1 (en) 2003-11-20 2005-05-26 Horng Liou L. Skin adherent hydrogels
JP2005306746A (ja) 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
EP1948236B1 (en) * 2005-09-27 2021-03-03 Special Water Patents B.V. Methods and compositions for treatment of skin
CN1969802A (zh) * 2005-11-25 2007-05-30 王立君 水溶性壳聚糖作为护肤品的应用
JPWO2008035563A1 (ja) * 2006-09-21 2010-01-28 ライオン株式会社 毛髪化粧料
EP2077819A4 (en) * 2006-09-28 2011-05-25 Follica Inc METHODS, MATERIALS, AND COMPOSITIONS FOR GENERATING NEW CELLULAR FOLLICLES AND PUSHING HAIR
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
EP2120845B1 (de) * 2007-02-21 2012-10-24 ROVI Cosmetics International GmbH Nanopartikel zur verwendung in kosmetischen und dermatologischen zubereitungen
DE102007039519A1 (de) * 2007-08-21 2009-02-26 Henkel Ag & Co. Kgaa Kosmetische Mittel mit Chitosan und Silikonelastomeren

Also Published As

Publication number Publication date
PE20110414A1 (es) 2011-06-25
EP3733192B1 (en) 2024-07-24
BRPI0917231B1 (pt) 2019-02-12
SI2307031T1 (sl) 2020-11-30
JP2011529938A (ja) 2011-12-15
RS60781B1 (sr) 2020-10-30
AU2009278086A1 (en) 2010-02-11
CA2732582A1 (en) 2010-02-11
CN102112137A (zh) 2011-06-29
WO2010015556A1 (en) 2010-02-11
PT2307031T (pt) 2020-08-05
EP2307031A1 (en) 2011-04-13
DK2307031T3 (da) 2020-08-31
NZ590796A (en) 2013-01-25
KR20110050464A (ko) 2011-05-13
EP3733192A1 (en) 2020-11-04
IL210920A (en) 2014-09-30
BRPI0917231A2 (pt) 2015-11-10
CY1123334T1 (el) 2022-03-24
MY158566A (en) 2016-10-14
CN105194675A (zh) 2015-12-30
IL210920A0 (en) 2011-04-28
EA021133B1 (ru) 2015-04-30
ES2820304T3 (es) 2021-04-20
AU2009278086A2 (en) 2011-03-03
AR072912A1 (es) 2010-09-29
US8303997B2 (en) 2012-11-06
EP2307031B1 (en) 2020-07-29
JP5677299B2 (ja) 2015-02-25
ZA201100706B (en) 2012-05-01
KR101661251B1 (ko) 2016-09-29
CA2732582C (en) 2016-01-19
LT2307031T (lt) 2020-09-25
EP2153836A1 (en) 2010-02-17
MA32600B1 (fr) 2011-09-01
EA201100242A1 (ru) 2011-08-30
US20110183016A1 (en) 2011-07-28
HRP20201385T1 (hr) 2021-04-02
AU2009278086B2 (en) 2014-04-24
MX2011001380A (es) 2011-04-21
HUE052093T2 (hu) 2021-04-28

Similar Documents

Publication Publication Date Title
CL2011000222A1 (es) Uso de una composicion que contiene a) quitosano o hidroxipropil quitosano, b) al menos un ingrediente seleccionado de inhibidores de alfa-5-reductasa, hormonas antiandrogenicas, agonistas del canal de potasio y extractos vegetales, c) etanol o isopropanol, para el tratamiento o prevencion de afecciones del cabello o cuero cabelludo tales como caida del cabello, alopecia, alopecia androgenica, entre otras.
DOP2022000124A (es) Derivados de pirazolilo útiles como agentes anticancerígenos
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
CR10408A (es) Composiciones novedosas para el trastornos del cabello y procedimiento de preparacion de las mismas
CL2011003266A1 (es) Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras.
SG165314A1 (en) Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
CL2012001971A1 (es) Compuestos derivados de 1-piperazinil-3-piridin-carboxilato, como bloqueadores de los canales de sodio dependientes de voltaje; composicion farmaceutica; y su uso para el tratamiento de enfermedades respiratorias o del tracto respiratorio tal como asma, epoc, tos, silicosis, entre otras.
CL2011000835A1 (es) Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras.
CR20110599A (es) Composiciones farmacéuticamente activas que comprenden moduladores de estrés oxidativo (osm), nuevas entidades químicas, composiciones y usos
CL2009000394A1 (es) Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer.
CL2011001658A1 (es) Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor.
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
CO6470821A2 (es) Pirazinilpirazoles
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
MX2013005995A (es) Composicion topica que promueve la melanina.
NO20090407L (no) Aerosolformulering for inhalering av beta agonister
CL2009001215A1 (es) Composiciones farmaceuticas que comprenden un primer agente seleccionado del grupo consistente de i) un agente antiinflamatorio, ii) acetaminofeno, iii) fenacetina, iv) tramadol, y un segundo agente; uso de dichas composiciones para tratar enfermedades proliferativas incluyendo cancer.
CL2011000341A1 (es) Compuestos derivados de pirrolidinona sustituida, moduladores de la actividad de ar para la inhibicion de ntd; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de cancer, acne, hirsutismo, entre otras.
CL2007002862A1 (es) Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha.
PE20200600A1 (es) Composiciones y metodos para promover el crecimiento del cabello con inhibidores de mpc
CL2012000097A1 (es) Compuestos derivados de 3-fenoximetilpirrolidina, inhibidores de la recaptacion de serotonina-norepinefrina; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica que lo comprende; y su uso en el tratamiento de trastornos del dolor, depresion, entre otros.
CL2009000636A1 (es) Compuestos derivados de 1-(1h-pirazol-3-il)-imidazolidin-4-ona sustituidos; procedimiento de preparacion de los compuestos; composicion farmaceutica; y su uso en el tratamiento de enfermedades retrovirales, tal como infeccion por vih.
AR073057A1 (es) Combinaciones insecticidas de abamectina y ciflumetofeno y composiciones que las comprenden.
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis